Viridian Therapeutics, Inc./DE Accounts Payable
Viridian Therapeutics, Inc./DE (VRDN) had Accounts Payable of $8.65 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $8.65M.
- 2026-03-31: Accounts Payable, Current $13.31M.
- 2025-12-31: Accounts Payable, Current $8.68M.
- 2025-09-30: Accounts Payable, Current $10.06M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.65M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $13.31M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $8.68M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $10.06M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $8.52M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $3.89M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $2.14M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $6.34M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.14M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.68M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $2.24M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $3.73M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.13M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $7.87M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $14.23M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $12.15M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.06M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.54M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.33M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.73M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $2.39M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.38M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $670.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $232.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $286.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.63M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.23M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $517.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $571.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.21M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $461.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $760.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $906.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $409.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $632.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.01M 10-K · filed 2018-03-15 | $159.00K 10-K · filed 2017-03-24 |
| 2016-09-30 | $51.00K 10-Q · filed 2016-10-26 | |
| 2016-06-30 | $94.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $102.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $242.00K 10-K · filed 2017-03-24 | |
| 2015-09-30 | $195.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $332.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $384.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $255.00K 10-K · filed 2016-03-21 | |
| 2014-09-30 | $238.52K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $167.74K 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $100.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |